Terms: = Uterine cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Staging
37 results:
1. Ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract] [Full Text] [Related]
2. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
[TBL] [Abstract] [Full Text] [Related]
3. Assessment of cervical vascularization density in patients with locally advanced squamous cell cervical carcinoma evaluated in colour Doppler and power Doppler functions.
Tomalczyk A; Tomasik B; Fijuth J; Moszynska-Zielinska M; Gottwald L
Arch Gynecol Obstet; 2022 Apr; 305(4):955-961. PubMed ID: 34586470
[TBL] [Abstract] [Full Text] [Related]
4. The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer.
Varela Cagetti L; Gonzague-Casabianca L; Zemmour C; Lambaudie E; Houvenaeghel G; Provansal M; Sabatier R; Sabiani L; Blache G; Jauffret C; Ferré M; Mailleux H; Paciencia M; Tallet A
Gynecol Oncol; 2021 Apr; 161(1):166-172. PubMed ID: 33563488
[TBL] [Abstract] [Full Text] [Related]
5. Acute Toxicity and Local Response using Three Fractions of High Dose Rate (hdr) Brachytherapy for Curative Treatment of Carcinoma Cervix.
Ali N; Qureshi BM; Abbasi AN; Hafiz A; Khan BM; Jangda AQ
J Coll Physicians Surg Pak; 2020 Sep; 30(9):974-979. PubMed ID: 33036685
[TBL] [Abstract] [Full Text] [Related]
6. The vaginal cylinder: Misunderstood, misused, or trivial? An in-depth dosimetric and multiinstitutional outcome investigation.
Guy CL; Fields EC; Quinn BA; Fisher CM; Ladbury CJ; Romano KD; Todor D
Brachytherapy; 2019; 18(6):763-770. PubMed ID: 31558353
[TBL] [Abstract] [Full Text] [Related]
7. Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach.
Draghini L; Costantini S; Vicenzi L; Italiani M; Loreti F; Trippa F; Arcidiacono F; Casale M; Mantello G; Maranzano E
Radiol Med; 2019 Sep; 124(9):819-825. PubMed ID: 30904982
[TBL] [Abstract] [Full Text] [Related]
8. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma.
Jordan SE; Micaily I; Hernandez E; Ferriss JS; Miyamoto CT; Li S; Micaily B
Brachytherapy; 2017; 16(6):1144-1151. PubMed ID: 28958736
[TBL] [Abstract] [Full Text] [Related]
9. Image-guided tandem and cylinder brachytherapy as monotherapy for definitive treatment of inoperable endometrial carcinoma.
Gebhardt B; Gill B; Glaser S; Kim H; Houser C; Kelley J; Sukumvanich P; Edwards R; Comerci J; Olawaiye A; Courtney-Brooks M; Boisen M; Berger J; Beriwal S
Gynecol Oncol; 2017 Nov; 147(2):302-308. PubMed ID: 28923412
[TBL] [Abstract] [Full Text] [Related]
10. FIGO stage IB1 cervical carcinoma: Place and principles of brachytherapy.
Huertas A; Oldrini S; Nesseler JP; Courrech F; Rétif P; Charra-Brunaud C; Peiffert D
Cancer Radiother; 2017 Apr; 21(2):155-163. PubMed ID: 28233697
[TBL] [Abstract] [Full Text] [Related]
11. Vaginal-cuff control and toxicity results of a daily hdr brachytherapy schedule in endometrial cancer patients.
Ríos I; Rovirosa A; Ascaso C; Valduvieco I; Herreros A; Castilla L; Sabater S; Holub K; Pahisa J; Biete A; Arenas M
Clin Transl Oncol; 2016 Sep; 18(9):925-30. PubMed ID: 26661111
[TBL] [Abstract] [Full Text] [Related]
12. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical cancer: 4-Year Outcomes.
Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
[TBL] [Abstract] [Full Text] [Related]
13. Sequential versus "sandwich" sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinoma.
Lu SM; Chang-Halpenny C; Hwang-Graziano J
Gynecol Oncol; 2015 Apr; 137(1):28-33. PubMed ID: 25666606
[TBL] [Abstract] [Full Text] [Related]
14. Neoadjuvant radiotherapy with or without chemotherapy followed by extrafascial hysterectomy for locally advanced endometrial cancer clinically extending to the cervix or parametria.
Vargo JA; Boisen MM; Comerci JT; Kim H; Houser CJ; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Huang M; Courtney-Brooks M; Beriwal S
Gynecol Oncol; 2014 Nov; 135(2):190-5. PubMed ID: 25218303
[TBL] [Abstract] [Full Text] [Related]
15. Patterns of care in patients with cervical cancer 2012: results of a survey among German radiotherapy departments and out-patient health care centers.
Marnitz S; Köhler C; Rauer A; Schneider A; Budach V; Tsunoda A; Mangler M
Strahlenther Onkol; 2014 Jan; 190(1):34-40. PubMed ID: 23887709
[TBL] [Abstract] [Full Text] [Related]
16. Postoperative pain medication requirements in patients undergoing computer-assisted (“Robotic”) and standard laparoscopic procedures for newly diagnosed endometrial cancer.
Leitao MM; Malhotra V; Briscoe G; Suidan R; Dholakiya P; Santos K; Jewell EL; Brown CL; Sonoda Y; Abu-Rustum NR; Barakat RR; Gardner GJ
Ann Surg Oncol; 2013 Oct; 20(11):3561-7. PubMed ID: 23797751
[TBL] [Abstract] [Full Text] [Related]
17. Ultrasound-assisted endocavitary hdr-Ir(192) brachytherapy for unresectable locally advanced uterine cervix carcinoma: retrospective analysis focusing the efficacy and tolerability.
Koukourakis GV; Miliadou A; Tsalafoutas I; Gkeli MG; Sotiropoulou-Lontou A
Clin Transl Oncol; 2013 Feb; 15(2):154-9. PubMed ID: 22855184
[TBL] [Abstract] [Full Text] [Related]
18. Treatment results of radical radiotherapy of carcinoma uterine cervix using external beam radiotherapy and high dose rate intracavitary radiotherapy.
Azad SK; Choudhary V
J Cancer Res Ther; 2010; 6(4):482-6. PubMed ID: 21358085
[TBL] [Abstract] [Full Text] [Related]
19. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: the Indiana University experience.
Fakiris AJ; Henderson M; Lo SS; Look KY; Cardenes HR
Brachytherapy; 2010; 9(1):61-5. PubMed ID: 20129252
[TBL] [Abstract] [Full Text] [Related]
20. [The role of PET in the diagnosis and prediction of the treatment response in patients with cervical carcinoma treated with radiotherapy--results of pilot study].
Dolezelová H; Slampa P; Ondrová B; Bolcák K; Gombosová J; Sovadinová S; Novotný T; Růzicková J; Hynková L; Opletal P; Forbelská M
Klin Onkol; 2008; 21(2):66-70. PubMed ID: 19102214
[TBL] [Abstract] [Full Text] [Related]
[Next]
